Trial Profile
Randomized Controlled Trial of Pirfenidone in Patients With Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Interstitial lung diseases
- Focus Therapeutic Use
- 13 Jul 2016 New trial record